| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | SERES THERAPEUTICS INC | 14,083,579 | 374,060,000 | 97.96% | ||
| 2 | T2 BIOSYSTEMS INC | 741,755 | 7,314,000 | 1.92% | ||
| 3 | ELEVEN BIOTHERAPEUTICS INC | 1,466,417 | 469,000 | 0.12% |
Portfolio data is normalized using SEC Form 13F filings, including the Restatement filing (0000950123-16-017855, filed 2016.06.03).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
